![]()
CYTOCHROME b (MTCYB)
|
![]() |
DESCRIPTION - Mitochondrial DNA Analysis
Mutations of the mitochondrially encoded human cytochrome b gene (MTCYB) are almost exclusively associated with isolated complex III deficiency in muscle. Cytochrome b is essential for assembly and function of complex III. Cytochrome b is the only protein subunit of complex III (ubiquinol-cytochrome c oxidoreductase). Complex III is a hydrophobic integral membrane protein with eight transmembrane helices and contains 11 polypeptides. In many patients the mutation appears to arise sporadically and is restricted to muscle tissue. This most often affects young adults who display skeletal muscle weakness and exercise intolerance, and may also exhibit myoglobinuria and mitochondrial proliferation as evidenced by the presence of ragged-red fibers (RRF) on muscle biopsy. Children with cytochrome b mutations have been reported and display mitochondrial encephalopathy, cardiomyopathy, septo-optic dysplasia, and multisystem disorders.
| Test Order Code | CYTB |
| CPT Codes |
83891 x 1, 83898 x 4, 83904 x 8 |
| Indications For Testing |
|
| Turn Around Time | Less than two weeks. Expedited analysis is available upon request for an additional charge. |
| Specimen Requirements |
Ship one of the following:
Saliva
Peripheral Blood Muscle Biopsy
|
| Specimen Kits | DNA Specimen Collection Kits can be obtained from Transgenomic Labs. |
| Shipping and Contact Information |
Transgenomic Labs Five Science Park, New Haven, CT 06511 USA Phone:1.877.274.9432 Fax: 203.786.3418 E-mail: labservice@transgenomiclabs.com |
| Test Submission and Patient Consent Forms |
Test Requisition and Patient Consent Form Due to the unique nature of genetic testing, patients should receive pre-test and post-test counseling. Informed consent is recommended. |
| Test Methodology | Genomic DNA is amplified by PCR for the specification region of interest and sequenced for confirmation. |
Additional References
Mitomap
A human mitochondrial genome database.
http://www.mitomap.org/
Note: The performance characteristics of this test were validated by Transgenomic Labs. The U.S. Food and Drug Administration (FDA) has not approved this test. However, FDA approval is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. Transgenomic Labs is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.